Mitochondrial complex i modulator for use in the treatment of arthritis
CA3329465A1Undetermined Publication Date: 2025-11-13MODERN BIOSCI LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3329465
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2025-05-09
- Publication Date
- 2025-11-13
Abstract
The invention provides mitochondrial complex I modulator (MCIM) compounds, which find utility in the treatment of arthritis, such as RA. The MCIM compounds find further utility in the treatment of physical functional decline and physical disabilities, such as age-related functional decline and disabilities. Treatment with MCIM compounds repair damage caused by arthritic disease and functional decline to improve patient quality of life.
Need to check novelty before this filing date? Find Prior Art
